Clinical trial
Study to Help Understand the Action of the Drug Etanercept for the Adult Patient…
NCT00116181 · Rockefeller University, Other · Completed
Key facts
| NCT number | NCT00116181 |
|---|---|
| Title | Study to Help Understand the Action of the Drug Etanercept for the Adult Patient With Psoriasis |
| Official title | A Multicenter, Open-Label, Prospective Study to Evaluate the Effectiveness and Safety of Etanercept in the Treatment of Subjects With Psoriasis-EASE in Psoriasis |
| Lead sponsor | Rockefeller University, Other |
| Collaborators | Amgen Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Psoriasis |
| Intervention type | Drug |
| Interventions | Etanercept |
| Enrollment | 30 |
| Start date | Oct 1, 2004 |
| Primary completion | Jan 1, 2007 |
| First posted | Jun 28, 2005 |
| Last update posted | Mar 18, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: